MARKET

HTMDF

HTMDF

HANGZHOU TIGERMED CONSULTING ORD
OTCPK
--
NaN%
Opening
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Harding Loevner Chinese Equity Q3 2024 Report
Seeking Alpha · 11/06/2024 15:05
abrdn China A Share Equity Fund Q2 2024 Commentary
Seeking Alpha · 08/28/2024 11:45
About HTMDF
Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The Company operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The Company conducts its businesses in the domestic and overseas markets.

Webull offers Hangzhou Tigermed Consulting Co Ltd stock information, including OTCPK: HTMDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HTMDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HTMDF stock methods without spending real money on the virtual paper trading platform.